NCT00005995
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Aeterna Zentaris Québec, Quebec, Canada
Clinical trial condition
Carcinoma
Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.
8,792 public trials
2,090 recruiting studies
Carcinoma trial results
Completed
Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer
NCT00101114
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00096512
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States
NCT00029003
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +17 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer
NCT00060307
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
NCT00087412
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +18 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer
NCT00068783
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
- Locations
-
- Southwest Oncology Group San Antonio, Texas, United States
Completed
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
NCT00215605
- Conditions
- Adenocarcinoma, Cancer, Carcinoma, +23 more
- Locations
-
- University of Chicago Chicago, Illinois, United States
- Johns Hopkins University Baltimore, Maryland, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Completed
Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
NCT00071994
- Conditions
- Adenocarcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, +12 more
- Locations
-
- Eastern Cooperative Oncology Group Boston, Massachusetts, United States